IDH2 and central nervous system cancer: A recent study outlined a novel mechanism involved in the pathogenesis of IDH-mutant gliomas: methylation of insulator protein binding sites within DNA, leading to aberrant contact of the PDGFRA promoter with distant enhancer elements, causing overexpression of PDGFRA, a known glioma oncogene (42).